Compendium of the most significant studies with reference to properties, intake, effects.

Sjuls S, Jensen U, Littmann K, Bruchfeld A, Brinck J. Effective cholesterol lowering after myocardial infarction in patients with nephrotic syndrome may require a multi-pharmacological approach: a case report. Eur Heart J Case Rep. 2021 May 13;5(5):ytab151. doi: 10.1093/ehjcr/ytab151.

Boutari C, Karagiannis A, Athyros VG. Rosuvastatin and ezetimibe for the treatment of dyslipidemia and hypercholesterolemia. Expert Rev Cardiovasc Ther. 2021 Jun 15:1-6. doi: 10.1080/14779072.2021.1940959. 

Salgado MM, Manchado A, Nieto CT, Díez D, Garrido NM. Synthesis and Modeling of Ezetimibe Analogues. Molecules. 2021 May 22;26(11):3107. doi: 10.3390/molecules26113107.

Reynolds TM, Pottle A, Quoraishi SH. Current Perspectives on the Attainment of Lipid Modification Goals Relating to the Use of Statins and Ezetimibe for the Prevention of Cardiovascular Disease in the United Kingdom. Vasc Health Risk Manag. 2021 May 21;17:227-237. doi: 10.2147/VHRM.S269879.

Lowenstern A, Li S, Navar AM, Virani SS, Roger VL, Robinson JG, Goldberg AC, Kampman W, Peterson ED, Wang TY. Patient perceptions and use of non-statin lipid lowering therapy among patients with or at risk for atherosclerotic cardiovascular disease: Insights from the PALM registry. Clin Cardiol. 2021 Jun;44(6):863-870. doi: 10.1002/clc.23625.

Yamashita S, Masuda D, Harada-Shiba M, Arai H, Bujo H, Ishibashi S, Daida H, Koga N, Oikawa S; FAME Study Group. Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study. J Atheroscler Thromb. 2021 May 13. doi: 10.5551/jat.62764. 

Barrios V, Escobar C. Fixed-dose combination of rosuvastatin and ezetimibe: treating hypercholesteremia according to cardiovascular risk. Expert Rev Clin Pharmacol. 2021 May 24:1-14. doi: 10.1080/17512433.2021.1925539.

Diaconu CC, Iorga RA, Furtunescu F, Katsiki N, Stoian AP, Rizzo M. Statin intolerance: new data and further options for treatment. Curr Opin Cardiol. 2021 Jul 1;36(4):487-493. doi: 10.1097/HCO.0000000000000874.

Lui DTW, Lee ACH, Tan KCB. Management of Familial Hypercholesterolemia: Current Status and Future Perspectives. J Endocr Soc. 2020 Aug 21;5(1):bvaa122. doi: 10.1210/jendso/bvaa122.